Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II trials demonstrate ability of Onco TCS to reduce tumor size in NHL patients

Nov. 6, 1998

Chinese researchers synthesize cytotoxic alkaloid derivative HH-07A

Nov. 6, 1998

Licensing opportunity from the NIH: method of inhibiting HGF/SF cleavage, activation

Nov. 5, 1998

Irreversible inactivators of EGF receptor TK hold promise as antitumor agents

Nov. 5, 1998

NAALADase inhibitors now reported to be useful for prostate cancer; patents issued

Nov. 3, 1998

Mitomycin C derivative shows therapeutic potential in treating bladder carcinoma

Nov. 3, 1998

Impressive results obtained with C225 in combination with radiotherapy in head and neck cancer

Nov. 3, 1998

Oncocidin A1: a novel microtubule-binding antitumor agent

Nov. 2, 1998

FDA approves Nolvadex for prevention of breast cancer

Oct. 30, 1998

FDA Oncologic Drugs Advisory Committee meets for two days in November

Oct. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...